Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation

Journal of Clinical Microbiology

Volumn 34, Issue 7, 1996, Pages 1849-1853

  Shafer, Robert W ^a   Winters, Mark A ^a   Mayers, Douglas L ^b   Japour, Anthony J ^c   Kuritzkes, Daniel R ^d   Weislow, Owen S ^b   White, Frank ^b   Erice, Alejo ^e   Sannerud, Kim J ^e   Iversen, Astrid ^a   Pena, Frank ^f   Dimitrov, Dimitri ^g   Frenkel, Lisa M ^h   Reichelderfer, Patricia S ^b,i  

^a STANFORD UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CODON; DRUG RESISTANCE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS MUTANT;

EID: 8944244060     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.7.1849-1853.1996     Document Type: Article

References (21)

1. Boucher, C. A. B., E. O'Sullivan, J. W. Mulder, C. Ramautarsing, P. Kellam, G. Darby, J. M. A. Lange, J. Goudsmit, and B. A. Larder. 1992. Ordered appearance of zidovudine (AZT) resistance mutations during treatment. J. Infect. Dis. 165:105-110.
2. D'Aquila, R. T., V. A. Johnson, S. L. Welles, A. J. Japour, D. R. Kuritzkes, V. DeGruttola, P. S. Reichelderfer, R. W. Coombs, C. S. Crumpacker, J. O. Kahn, and D. D. Richman, for the AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group. 1995. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. Ann. Intern. Med. 122:401-408.
3. Eastman, P. S., E. Boyer, L. Mole, J. Kolberg, M. Urdea, and M. Holodniy. 1995. Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance. J. Clin. Microbiol. 33:2777-2780.
4. Erice, A., and H. H. Balfour, Jr. 1994. Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review. Clin. Infect. Dis. 18: 149-156.
5. Frenkel, L. M., L. E. Wagner II, S. M. Atwood, T. J. Cummins, and S. Dewhurst. 1995. Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine. J. Clin. Microbiol. 33:342-347.
6. Gingeras, T. R., P. Prodanovich, T. Latimer, J. C. Guatelli, D. D. Richman, and K. J. Barringer. 1991. Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus. J. Infect. Dis. 164:1066-11174.
7. Japour, A. J., S. Welles, R. T. D'Aquila, V. A. Johnson, D. D. Richman, R. W. Coombs, P. S. Reichelderfer, J. O. Kahn, C. S. Crumpacker, and D. R. Kuritzkes for the AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group. 1995. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. J. Infect. Dis. 171:1172-1179.
8. Kaye, S., E. Comber, M. Tenant-Flowers, and C. Loveday. 1995. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA. AIDS Res. Hum. Retroviruses 11:1221-1225.
9. Kaye, S., C. Loveday, and R. S. Tedder. 1992. A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J. Med. Virol. 37:241-246.
10. Kozal, M. J., R. W. Shafer, M. A. Winters, D. A. Katzenstein, and T. C. Merigan. 1993. A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numhers in long-term zidovudine recipients. J. Infect. Dis. 167:526-532.
11. Kwok, S., S. Y. Chang, J. J. Sninsky, and A. Wang. 1994. A guide to the design and use of mismatched and degenerate primers. PCR Methods Appl. 3:S39-S47.
12. Larder, B. A., and C. A. B. Boucher. 1995. PCR detection of human immunodeficiency virus drug resistance mutations, p. 527-533. In D. H. Persing. T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
13. Larder, B. A., P. Kellam, and S. D. Kemp. 1991. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 5:137-144.
14. Richman, D. D. 1993. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37: 1207-1213.
15. Richman, D. D., J. C. Guatelli, J. Grimes, A. Tsiatis, and T. Gingeras. 1991. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction. J. Infect. Dis. 164:1075-1081.
16. Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignacio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Barringer, D. Pauletti, C.-K. Shih, M. Myers, and J. Griffin. 1994. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666.
17. Schuurman, R., M. Nijhuis, R. van Leeuwen, P. Schipper, D. de Jong, P. Collis, S. A. Danner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171:1411-1419.
18. Shafer, R. W., M. J. Kozal, M. A. Winters, A. K. Iversen, D. A. Katzenstein, M. V. Ragni, W. A. Meyer, P. Gupta, S. Rasheed, R. Coombs, and T. C. Merigan. 1994. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J. Infect. Dis. 169:722-724.
19. Shafer, R. W., and T. C. Merigan. 1995. HIV virology for clinical trials. AIDS 9(Suppl. A):S193-S202.
20. St. Clair, M., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253:1557-1559.
21. Tada, M., M. Omata, S. Kawai, H. Saisho, M. Ohio, R. K. Saiki, and J. J. Sninsky. 1993. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 53:2472-2474.